Arterial Septal Defect (Asd)
Arterial Septal Defect (Asd)
CASE REPORT
PATIENT IDENTITY
NAME
AGE
SEX
: MS. D
: 29 YO
: FEMALE
CHIEF COMPLAIN
Breathlesness
hospitalized
since
weeks
before
PHYSICAL EXAMINATION
General appearence : Moderete illness
Consiusness
: Composmentis
Vital sign
Blood pressure
: 110/70 mmHg
Heart rate
: 96 x/i
Respiration rate
: 28 x/i
Temperature
: 36 C
HEAD
Pale
THORAX
HEART
Inspection
: Ictus cordis (-)
Palpation
: Ictus cordis (+) SIC 4
midclavicula
Percution
Right border : Parasternalis line dextra, SIC
4
Left border : Midclavicula line sinistra, SIC
5
Auskultation : S1 and S2 regullar, murmur
sistolyc (+), gallop (-)
LUNG
Inspection
: Simetric (+/+), mass (-),
Palpation
: Vocal Fremitus (+/+)
Percution
: Sonor in all Field of thorax
Auskultation :Vesikuler (+/+), ronkhi (-/-),
wheezing (-/-)
STOMACH
Inspection : mass (-), scar (-)
Auscultation : intestine sound (+)
Percution
: tympany
Palpation
: Hepatomegaly (-),
splenomegaly (-)
EKSTREMITY
WORKING DIAGNOSIS
ADDITIONAL EXAMINATION
Blood routine
Electrocardiogram
Rontgen thorax
Echocardiografi
LABORATORY FINDING
Eritosite
:
Leukocyte
Hemogloblin :
Hematocrite :
Platelet
:
5.360.000 /uL
: 12.500 /uL
15 g/dl
45 %
215.000/ uL
ELECTROCARDIOGRAM
Appear :
Irama : sinus, reguler.
Ritmik : 115 bpm (sinus takikardi)
P wave : wide 0,08 second (normaly)
Length 1 mm
Interval PR : 0,16 second ( normaly)
Interval QRS : 0,08 second ( normaly)
Complex QRS: ST segmen normaly
T wave : Normaly
RONTGEN THORAX
Right identity
R marker
Opacity is good
CTR > 50% (52%)
Heart waist (+)
Hiperbronchovascular
ECHOCARDIOGRAFI
APPEAR ECHOCARDIOGRAFI
DIAGNOSIS
TREATMENT
Non farmacology:
Bed rest ( fowler position )
O2 2 liter nasal canul
Farmacology :
Furosemid 3x 20 mg
Digosin 1x 0,25 mg
Ranitidin 2 x 50 mg
DEFINITION
ASD is an opening or hole (defect) in the wall
(septum) between the hearts two upper chambers
(atria)
ETIOLOGY
PATOFISIOLOGY
Class IIa
1. Maximal exercise testing can be useful to
document exercise capacity in patients with
symptoms that are discrepant with clinical
findings or to document changes in oxygen
saturation in patients with mild or moderate
PAH. (Level of Evidence: C)
2. Cardiac catheterization can be useful to rule out
concomitant coronary artery disease in patients
at risk because of age or other factors. (Level of
Evidence: B)
Class III
1. In younger patients with uncomplicated
ASD for whom imaging results are adequate,
diagnostic cardiac catheterization is not
indicated. (Level of Evidence: B)
2. Maximal exercise testing is not
recommended in ASD with severe PAH. (Level
of Evidence: B)
MANAGEMENT STRATEGIES
Recommendations for Medical Therapy
Class I
1. Cardioversion after appropriate
anticoagulation is recommended to attempt
restoration of the sinus rhythm if atrial
fibrillation occurs. (Level of Evidence: A)
Class I
1. Closure of an ASD either percutaneously or
surgically is indicated for right atrial and RV
enlargement with or without symptoms. (Level
of Evidence: B)
2. A sinus venosus, coronary sinus, or primum
ASD should be repaired surgically rather than
by percutaneous closure. (Level of Evidence: B)
3. Surgeons with training and expertise in
CHD should perform operations for various
ASD closures. (Level of Evidence: C)
Class IIa
1. Surgical closure of secundum ASD is reasonable
when
concomitant surgical repair/replacement of a tricuspid
valve is considered or when the anatomy of the defect
precludes the use of a percutaneous device. (Level of
Evidence: C)
2. Closure of an ASD, either percutaneously or
surgically,
is reasonable in the presence of:
a. Paradoxical embolism. (Level of Evidence: C)
b. Documented orthodeoxia-platypnea. (Level of
Evidence:
B)
Class IIb
1. Closure of an ASD, either percutaneously or surgically,
may be considered in the presence of net left-to-right
shunting, pulmonary artery pressure less than two
thirds systemic levels, PVR less than two thirds systemic
vascular resistance, or when responsive to either
pulmonary vasodilator therapy or test occlusion of the
defect (patients should be treated in conjunction with
providers who have expertise in the management of
pulmonary hypertensive syndromes). (Level of Evidence:
C)
2. Concomitant Maze procedure may be considered for
intermittent or chronic atrial tachyarrhythmias in
adults with ASDs. (Level of Evidence: C)
Class III
1. Patients with severe irreversible PAH and
no evidence
of a left-to-right shunt should not undergo
ASD closure.
(Level of Evidence: B)
CATHETER INTERVENTION
The development of percutaneous transcatheter
closure
techniques has provided an alternative method of
closure
for uncomplicated secundum ASDs with
appropriate morphology.
the majority of secundum ASDs
can be closed with a percutaneous catheter
technique. When
this is not feasible or is not appropriate, surgical
closure is
recommended.
RECOMMENDATION FOR
REPRODUCTION
Class III
1. Pregnancy in patients with ASD and
severe PAH
(Eisenmenger syndrome) is not
recommended owing to
excessive maternal and fetal mortality and
should be
strongly discouraged. (Level of Evidence: A)
ACTIVITY
Patients with small ASDs and without PAH have
normal
exercise capacity and do not need any limitation
of physical
activity. In those patients with large left-to-right
shunts,
exercise is often self-limited owing to decreased
cardiopulmonary
function.